USA - NASDAQ:ARYD - KYG316591083 - Common Stock
The current stock price of ARYD is 6.64 USD. In the past month the price decreased by -42.01%. In the past year, price decreased by -35.72%.
ARYA Sciences Acquisition Corp. IV operates as a blank check company. The company is headquartered in New York City, New York. The company went IPO on 2021-02-26. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm is focused on healthcare or healthcare related industries. The firm has no operations and has not generated revenues.
ARYA SCIENCES ACQUISITION-A
51 Astor Place, 10Th Floor
New York City NEW YORK US
CEO: Adam Stone
Employees: 0
Phone: 12122842300
ARYA Sciences Acquisition Corp. IV operates as a blank check company. The company is headquartered in New York City, New York. The company went IPO on 2021-02-26. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm is focused on healthcare or healthcare related industries. The firm has no operations and has not generated revenues.
The current stock price of ARYD is 6.64 USD. The price decreased by -25.92% in the last trading session.
ARYD does not pay a dividend.
ARYD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
ARYA SCIENCES ACQUISITION-A (ARYD) currently has 0 employees.
You can find the ownership structure of ARYA SCIENCES ACQUISITION-A (ARYD) on the Ownership tab.
Over the last trailing twelve months ARYD reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -306.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.83% | ||
| ROE | -11.32% | ||
| Debt/Equity | 0.14 |